New mechanism for an old drug: aspirin triggers anti-inflammatory lipid mediators with gender implications.

Not yet translated Not yet translated
Authors
Category Primary study
JournalComprehensive therapy
Year 2006
Aspirin increases anti-inflammatory aspirin-triggered lipoxin A4 levels in healthy subjects in a gender-specific manner in a randomized clinical study. Thus, formation of aspirin-triggered lipoxin A4 may provide a novel mechanism underlying aspirin's clinical benefits, and shed light on gender-dependent therapeutics of aspirin.
Epistemonikos ID: 45d65d430542d3258e456d4dff3c607511909f60
First added on: Aug 31, 2023